维普中文期刊产品整合服务
73篇 您的检索式:作者名="BILIM V"
    题名 作者 年代 出处 被引量
1Glycogen synthase kinase-3! a new therapeutic target in renal cell carcinoma显示文摘Bilim V Ougolkov A Yuuki K 2009Br J Cancer2009,101,12:1
2Abnormal expression of Ecadherin, beta-catenin, and C-erbB-2 in advanced gastric cancer: its association with liver metastasis 显示文摘Ougolkov A Yamashita K Bilim V 2003Int J Colorectal Dis2003,18,2:1
3Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer:association with kinase activity and tumor dedifferentiatian 显示文摘Ougolkov AV Fernandez-Zapico ME Bilim V N 2006Chn Cancer Res2006,12,17:1
4Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-313显示文摘Tsukigi M Bilim V Yuuki K 2012Cancer Lett2012,315,2:1
5Technology evaluation: PK1, Pfizer/Cancer Research UK显示文摘BILIM V 2003Curt Opin Mol Ther2003,5,3:1
6Abnormal expression of E-cadherin, beta-catenin, and c-erbB-2 in advanced gastric cancer: its association with liver metastasis 显示文摘Ougolkov A Yamashita K Bilim V 2003Int J Colorectal Dis2003,18,:1
7Role of XIAP in the malignant phenotype of transitional cell eaneer(TCC) and the therapeutic activity ofXIAP antisense oligonucleotides against multidrug-resistant TCC in vitro显示文摘Bilim V Kasahara T Hara N 2003International Journal of Cancer2003,103,1:1
8Glycogen synthase kinase-3:a new therapeutic target in renal cell carcinoma显示文摘Bilim V Ougolkov A Yuuki K 2009Br J Cancer2009,101,12:1
9Prognostic impact of FAS/CD95/APO-1 in urothelial cancers: decreased expres- sion of Fas is associated with disease progression显示文摘Yamana K Bilim V Hara N 2005Br J Cancer2005,93,5:1
10Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer显示文摘Naito S Bilim V Yuuki K 2010Clinical Cancer Research2010,16,21:1
11Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2显示文摘Ougolkov A V Bilim V N Billadeau D D 2008Clin Cancer Res2008,14,21:1
12Abnormal expression of E-cadherin, betacatenin,and C-erbB-2 in advanced gastric cancer: its association with liver me- tastasis显示文摘Ougolkov A Yamashita K Bilim V 2003Int J Colorectal Dis2003,18,:1
13Abnormal expression of E-cadherin,beta-catenin,and c-erbB-2in advanced gastric cancer:its association with liver metastasis显示文摘Ougolkov A Yamashita K Bilim V 2003Int J Colorectal Dis2003,18,2:1
14Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma 显示文摘Bilim V Ougolkov A Yuuki K 2009Br J Cancer2009,101,12:1
15Double inhibition of XlAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis 显示文摘Bilim V Yuuki K Ihoi T 2008Cancer2008,98,5:1
16Role of XIAP in the malignant phenotype of transitional cell cancer (TCC)and therapeutic activity of XIAP antisense oligonucleotides against muhidrug-resistant TCC in vitro 显示文摘Bilim V Kasahara T Hara N 2003International Journal of Cancer2003,103,1:1
17Re-expression of miR- 199a suppresses renal cancer cell proliferation and survival by targeting GSK-3显示文摘Tsukigi M Bilim V Yuuki K 2012Cancer Lett2012,315,2:1
18Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one milliliter of peripheral blood: Value for the Staging of Prostate Cancer 显示文摘Hara N Kasahara T Kawasaki T Bilim V Obara K Takahashi K Tomita Y 2002Clin Cancer Res2002,8,6:1
19Role of XIAP in themalignant phe- notype of transitional cell cancer(TCC) and therapeutic activity of XIAP an tisense oligonucleotides against muhidrug-resist ant TCC in vitro显示文摘Bilim V Kasahara T HaraN 2003Int J Cancer2003,103,1:1
20Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma 显示文摘Bilim V Ougolkov A Yuuki K 2009Br J Cancer2009,101,12:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费